Development code · Biologic
MABT5102A
MABT5102A is a development code for Crenezumab, developed by AC Immune SA.
- Status
- Discontinued for Alzheimer's disease
- Mechanism
- Amyloid-beta (aggregated) Inhibitor
- Developer
- AC Immune SA
Programs
- Crenezumab for Alzheimer's diseaseDiscontinuedDiscontinued
Also known as
- RG7412
- RG-7412
- crenezumab